| Literature DB >> 27179994 |
Roz Laing1, Kirsty Maitland2, Lenka Lecová3, Philip J Skuce4, Andy Tait2, Eileen Devaney2.
Abstract
Sheep farmers in the UK rely on strategic anthelmintic use to treat and control gastrointestinal roundworms in their flocks. However, resistance to these drugs is now widespread and threatens the sustainability of sheep production. The mechanisms underlying resistance to the most commonly used class, the macrocyclic lactones, are not known and sensitive diagnostic tools based on molecular markers are not currently available. This prohibits accurate surveillance of resistance or assessment of strategies aimed at controlling its spread. In this study, we examined four UK field populations of Haemonchus contortus, differing in macrocyclic lactone treatment history, for evidence of selection at 'candidate gene' loci identified as determining macrocyclic lactone resistance in previously published research. Individual worms were genotyped at Hc-lgc-37, Hc-glc-5, Hc-avr-14 and Hc-dyf-7, and four microsatellite loci. High levels of polymorphism were identified at the first three candidate gene loci with remarkably little polymorphism at Hc-dyf-7. While some between-population comparisons of individual farms with and without long-term macrocyclic lactone use identified statistically significant differences in allele frequency and/or fixation index at the Hc-lgc-37, Hc-glc-5 or Hc-avr-14 loci, we found no consistent evidence of selection in other equivalent comparisons. While it is possible that different mechanisms are important in different populations or that resistance may be conferred by small changes at multiple loci, our findings suggest that these are unlikely to be major loci conferring macrocyclic lactone resistance on UK farms or suitable for diagnostic marker development. More powerful approaches, using genome-wide or whole genome sequencing, may be required to define macrocyclic lactone resistance loci in such genetically variable populations.Entities:
Keywords: Anthelmintic resistance; Ivermectin; Macrocyclic lactone; Nematode; Parasite; Sheep
Mesh:
Substances:
Year: 2016 PMID: 27179994 PMCID: PMC5011429 DOI: 10.1016/j.ijpara.2016.03.010
Source DB: PubMed Journal: Int J Parasitol ISSN: 0020-7519 Impact factor: 3.981
Anthelmintic use in ewes. F5+ and F101+ frequently use macrocyclic lactones, F86− and F102− rarely/never use macrocyclic lactones. Farm management data from Burgess et al. (2012).
| Farm | Drenches per year | Anthelmintic use in ewes | Dose to | Quarantine drench | Long acting drug at lambing | Confirmed AR | Dose and move | ML to treat ectoparasites | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | ||||||||
| F5+ | 1 | ML | ML | ML | ML | ML | ML | Estimate | ML | ML | No | No | No |
| F101+ | 2 | BZ, LV, ML | LV, ML | LV, ML | LV, ML | LV, ML | LV, ML | Estimate | ML | ML | No | Yes | No |
| F86- | 2 | LV | LV | BZ | LV | BZ | Heaviest | BZ, LV, ML | No | BZ | No | No | |
| F102- | 2 | BZ | BZ | BZ | BZ | LV | LV | Heaviest | No | No | No | Yes | No |
BZ, Benzimidazole; LV, Levamisole; ML, macrocyclic lactone.
Fixation index values for pairwise farm comparisons. F5+ and F101+ frequently use macrocyclic lactones, F86− and F102− rarely/never use macrocyclic lactones. Fixation index with 10 microsatellites shown in column 2 is from Redman et al. (2015).
| Farm comparison | FST with 10 microsatellites (with null correction) | FST with 4 microsatellites (with null correction) | FST with 4 microsatellites and 4 candidate gene loci |
|---|---|---|---|
| F86− and F101+ | 0.0115 (0.0121) | 0.0122 (0.0208) | 0.0143 |
| F86− and F5+ | – | 0.0158 (0.0180) | 0.0088 |
| F102− and F101+ | 0.0453 (0.0409) | 0.0231 (0.0193) | 0.0365 |
| F102− and F5+ | – | 0.0165 (0.0053) | 0.0362 |
| F86− and F102− | 0.0514 (0.0459) | 0.0363 (0.0237) | 0.0670 |
| F101+ and F5+ | – | 0.0165 (0.0135) | 0.0221 |
Fig. 1Principal Co-ordinate Analysis plots. The plots show individual Haemonchus contortus L1s from field populations without a history of macrocyclic lactone use (F102− and F86−) and field populations with a history of frequent macrocyclic lactone use (F101+ and F5+). The plots show little differentiation between individuals from different farm populations, other than some clustering of individuals from F102−, which is consistent with the Analysis of Molecular Variance partitioning of genetic variation and the population fixation index values.
Fig. 2Allele frequencies at four candidate gene loci in Haemonchus contortus. Column A shows allele frequencies in farm populations pooled by macrocyclic lactone treatment history. ML−, field populations without history of macrocyclic lactone use; ML+, field populations with a history of frequent macrocyclic lactone use. No significant differences in allele frequencies between ML− and ML+ populations were present. Column B shows allele frequencies in individual farm populations. Significant differences in allele frequencies were observed in some between-farm comparisons but not others. No consistent differences were observed between all ML− farms and all ML+ farms. See Table 3 for X2 analyses.
X2 analysis of candidate gene allele frequencies. F5+ and F101+ frequently use macrocyclic lactones, F86− and F102− rarely/never use macrocyclic lactones. Comparisons are shown for individual farms and for farms pooled by macrocyclic lactone use (ML− and ML+).
| Locus | Comparison | X2 | |
|---|---|---|---|
| F102− and F101+ | 12.29 | 0.006 | |
| F102− and F5+ | 1.91 | 0.591 | |
| F86− and F101+ | 2.89 | 0.409 | |
| F86− and F5+ | 6.74 | 0.081 | |
| ML− and ML+ | 2.17 | 0.540 | |
| F102− and F86− | 14.67 | 0.002 | |
| F101+ and F5+ | 5.09 | 0.165 | |
| F102− and F101+ | 4.05 | 0.130 | |
| F102− and F5+ | 14.85 | 0.001 | |
| F86− and F101+ | 6.27 | 0.043 | |
| F86− and F5+ | 0.41 | 0.816 | |
| ML− and ML+ | 1.52 | 0.470 | |
| F102− and F86− | 16.28 | 0.000 | |
| F101+ and F5+ | 7.01 | 0.030 | |
| F102− and F101+ | 14.35 | 0.006 | |
| F102− and F5+ | 7.11 | 0.130 | |
| F86− and F101+ | 2.83 | 0.587 | |
| F86− and F5+ | 2.80 | 0.592 | |
| ML− and ML+ | 3.84 | 0.428 | |
| F102− and F86− | 10.42 | 0.034 | |
| F101+ and F5+ | 8.75 | 0.068 | |
| F102− and F101+ | 0.62 | 0.430 | |
| F102− and F5+ | 0.00 | 0.964 | |
| F86− and F101+ | 0.11 | 0.740 | |
| F86− and F5+ | 0.26 | 0.609 | |
| ML− and ML+ | 0.06 | 0.814 | |
| F102− and F86− | 0.21 | 0.645 | |
| F101+ and F5+ | 0.71 | 0.398 | |
P < 0.05 was considered statistically significant.
Fig. 3Genomic sequence of Haemonchus contortus (Hc)-dyf-7. (A) Restriction fragment length polymorphism amplicons. S, macrocyclic lactone-susceptible isolate; R, macrocyclic lactone-resistant isolate, ML−, field population without a history of macrocyclic lactone use; ML+, field population with a history of frequent macrocyclic lactone use. Bullets above alleles highlight single nucleotide polymphisms associated with macrocyclic lactone resistance in Urdaneta-Marquez et al. (2014), with numbered bullets highlighting three single nucleotide polymphisms reported to most reliably predict macrocyclic lactone resistance status (single nucleotide polymphism nucleotide numbers correspond to those in Urdaneta-Marquez et al., 2014). Vertical lines in allele B sequences indicate all single nucleotide polymphisms relative to the allele A reference sequence. Only allele A was present in the five clones from the drug-susceptible laboratory isolate MHco3(ISE), while alleles A and B were present in the five clones from drug-resistant isolates MHco4(WRS) and MHco10(CAVR). Both alleles A and B were present in all farm populations, regardless of anthelmintic use history. WRS_3_R and CAVR_1_R appear to represent recombinant A/B and B/A alleles, respectively. Their un-nested (695 bp) amplicon sequences are shown in B, which extends to the thirteenth single nucleotide polymphism marker associated with macrocyclic lactone resistance in Urdaneta-Marquez et al. (2014). F86_13_ML- may be a B/A recombinant also. The Restriction fragment length polymorphism screen does not differentiate these recombinant alleles.